Literature DB >> 20620663

Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline.

Yi-Yu Chou1, Natasha Leporé, Priyanka Saharan, Sarah K Madsen, Xue Hua, Clifford R Jack, Leslie M Shaw, John Q Trojanowski, Michael W Weiner, Arthur W Toga, Paul M Thompson.   

Abstract

Ideal biomarkers of Alzheimer's disease (AD) should correlate with accepted measures of pathology in the cerebrospinal fluid (CSF); they should also correlate with, or predict, future clinical decline, and should be readily measured in hundreds to thousands of subjects. Here we explored the utility of automated 3D maps of the lateral ventricles as a possible biomarker of AD. We used our multi-atlas fluid image alignment (MAFIA) method, to compute ventricular models automatically, without user intervention, from 804 brain MRI scans with 184 AD, 391 mild cognitive impairment (MCI), and 229 healthy elderly controls (446 men, 338 women; age: 75.50 +/- 6.81 [SD] years). Radial expansion of the ventricles, computed pointwise, was strongly correlated with current cognition, depression ratings, Hachinski Ischemic scores, language scores, and with future clinical decline after controlling for any effects of age, gender, and educational level. In statistical maps ranked by effect sizes, ventricular differences were highly correlated with CSF measures of Abeta(1-42), and correlated with ApoE4 genotype. These statistical maps are highly automated, and offer a promising biomarker of AD for large-scale studies. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620663      PMCID: PMC2904619          DOI: 10.1016/j.neurobiolaging.2010.05.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  56 in total

Review 1.  Unfolding the human hippocampus with high resolution structural and functional MRI.

Authors:  M M Zeineh; S A Engel; P M Thompson; S Y Bookheimer
Journal:  Anat Rec       Date:  2001-04

2.  Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors.

Authors:  Martin Styner; Jeffrey A Lieberman; Robert K McClure; Daniel R Weinberger; Douglas W Jones; Guido Gerig
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-16       Impact factor: 11.205

3.  Brain structure and obesity.

Authors:  Cyrus A Raji; April J Ho; Neelroop N Parikshak; James T Becker; Oscar L Lopez; Lewis H Kuller; Xue Hua; Alex D Leow; Arthur W Toga; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2010-03       Impact factor: 5.038

4.  The topography of grey matter involvement in early and late onset Alzheimer's disease.

Authors:  Giovanni B Frisoni; Michela Pievani; Cristina Testa; Francesca Sabattoli; Lorena Bresciani; Matteo Bonetti; Alberto Beltramello; Kiralee M Hayashi; Arthur W Toga; Paul M Thompson
Journal:  Brain       Date:  2007-02-09       Impact factor: 13.501

5.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

6.  Predicting the rate of cognitive decline in aging and early Alzheimer disease.

Authors:  S Adak; K Illouz; W Gorman; R Tandon; E A Zimmerman; R Guariglia; M M Moore; J A Kaye
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

7.  Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.

Authors:  Shannon L Risacher; Andrew J Saykin; John D West; Li Shen; Hiram A Firpi; Brenna C McDonald
Journal:  Curr Alzheimer Res       Date:  2009-08       Impact factor: 3.498

8.  Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1.

Authors:  Oscar L Lopez; William J Jagust; Steven T DeKosky; James T Becker; Annette Fitzpatrick; Corinne Dulberg; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller
Journal:  Arch Neurol       Date:  2003-10

9.  Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry.

Authors:  April J Ho; Xue Hua; Suh Lee; Alex D Leow; Igor Yanovsky; Boris Gutman; Ivo D Dinov; Natasha Leporé; Jason L Stein; Arthur W Toga; Clifford R Jack; Matt A Bernstein; Eric M Reiman; Danielle J Harvey; John Kornak; Norbert Schuff; Gene E Alexander; Michael W Weiner; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2010-04       Impact factor: 5.038

10.  Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.

Authors:  K B Walhovd; A M Fjell; J Brewer; L K McEvoy; C Fennema-Notestine; D J Hagler; R G Jennings; D Karow; A M Dale
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

View more
  36 in total

Review 1.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

2.  Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Joshua D Grill; Lijie Di; Po H Lu; Cathy Lee; John Ringman; Liana G Apostolova; Nicole Chow; Omid Kohannim; Jeffrey L Cummings; Paul M Thompson; David Elashoff
Journal:  Neurobiol Aging       Date:  2012-04-13       Impact factor: 4.673

3.  The power of neuroimaging biomarkers for screening frontotemporal dementia.

Authors:  Corey T McMillan; Brian B Avants; Philip Cook; Lyle Ungar; John Q Trojanowski; Murray Grossman
Journal:  Hum Brain Mapp       Date:  2014-03-31       Impact factor: 5.038

Review 4.  Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.

Authors:  Meredith N Braskie; Paul M Thompson
Journal:  Trends Cogn Sci       Date:  2013-09-09       Impact factor: 20.229

5.  Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment.

Authors:  Liana Apostolova; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Jan Petter Larsen; Paul M Thompson; Yi-Yu Chou; Ole B Tysnes; Hege K Vefring; Mona K Beyer
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

6.  Structural Brain Changes in Early-Onset Alzheimer's Disease Subjects Using the LONI Pipeline Environment.

Authors:  Seok Woo Moon; Ivo D Dinov; Sam Hobel; Alen Zamanyan; Young Chil Choi; Ran Shi; Paul M Thompson; Arthur W Toga
Journal:  J Neuroimaging       Date:  2015-05-04       Impact factor: 2.486

Review 7.  The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?

Authors:  María C Rodriguez-Oroz; Belen Gago; Pedro Clavero; Manuel Delgado-Alvarado; David Garcia-Garcia; Haritz Jimenez-Urbieta
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

8.  Brain structure and aging in chronic temporal lobe epilepsy.

Authors:  Kevin Dabbs; Tara Becker; Jana Jones; Paul Rutecki; Michael Seidenberg; Bruce Hermann
Journal:  Epilepsia       Date:  2012-04-03       Impact factor: 5.864

9.  Surface fluid registration of conformal representation: application to detect disease burden and genetic influence on hippocampus.

Authors:  Jie Shi; Paul M Thompson; Boris Gutman; Yalin Wang
Journal:  Neuroimage       Date:  2013-04-13       Impact factor: 6.556

10.  Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.

Authors:  Kwangsik Nho; Shannon L Risacher; Paul K Crane; Charles DeCarli; M Maria Glymour; Christian Habeck; Sungeun Kim; Grace J Lee; Elizabeth Mormino; Shubhabrata Mukherjee; Li Shen; John D West; Andrew J Saykin
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.